JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function

Journal: Science Translational Medicine

Published: 2020-02-12

DOI: 10.1126/scitranslmed.aay4447

Affiliations: 4

Authors: 15

Go to article
Institutions Share
Department of Medicine 3 - Rheumatology and Immunology, FAU, Germany 0.48
Deutsches Zentrum Immuntherapie (DZI), FAU, Germany 0.48
Nikolaus Fiebiger Center of Molecular Medicine (NFZ), FAU, Germany 0.02
University Hospital of Erlangen, FAU, Germany 0.02

Return